Download PDF
Horm Metab Res 2016; 48(08): 497-502
DOI: 10.1055/s-0042-101550
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Influence of Vitamin D and Parathyroid Hormone on Bone and Metabolic Risk in Women with Previous Gestational Diabetes

M. C. Serra
1   Baltimore Maryland VA Medical Center & University of Maryland School of Medicine, Baltimore, MD, USA
,
A. S. Ryan
1   Baltimore Maryland VA Medical Center & University of Maryland School of Medicine, Baltimore, MD, USA
› Author Affiliations
Further Information

Publication History

received 04 August 2015

accepted 14 January 2016

Publication Date:
16 February 2016 (online)

Also available at
    Permissions and Reprints

Abstract

The purpose of this study was to compare plasma 25-hydroxyvitamin D [25(OH)D] and parathyroid hormone (PTH), VO2max, bone (by DXA), and metabolic outcomes across age and race-matched postmenopausal women (54±1 years; mean±SEM): 1) with previous gestational diabetes (GDM) (32±1 kg/m2; n=17), 2) without previous GDM, but with a similar BMI to GDM (32±1 kg/m2; n=17), and 3) without previous GDM, but with a higher BMI than GDM (36±1 kg/m2; n=17; p<0.01). The prevalence of 25(OH)D insufficiency and deficiency was high (~80%), but not different across groups, while PTH tended to be ~30% lower in women with a history of GDM (p=0.09). Women with a history of GDM had lower HDL cholesterol and higher diastolic blood pressure and fasting and 2-h glucose levels (by oral glucose tolerance test) (vs. groups 2 and 3; p<0.05). Bone mineral density (BMD) tended to be slightly higher in women with prior GDM than the BMI matched women with no prior GDM (p=0.09). Overall, higher PTH was associated with lower femoral neck (r=− 0.33) and (r=− 0.38) (p <0.05), while lower 25(OH)D was associated with lower VO2max (r=0.25, p=0.05) and higher fasting glucose (r=− 0.14) and insulin (r=− 0.29 (p <0.05). We observed that the poor metabolic profiles of postmenopausal women with a history of GDM are independent of 25(OH)D and PTH. However, due to associations between 25(OH)D and PTH with bone and metabolic outcomes, maintaining recommended 25(OH)D and PTH concentrations is important regardless of a previous history of GDM.

Key words

gestational diabetes mellitus - vitamin D - parathyroid hormone - metabolism - bone mineral density
 

  • References

  • 1 Gulseth HL, Gjelstad IM, Birkeland KI, Drevon CA. Vitamin D and the metabolic syndrome. Curr Vascul Pharmacol 2013; 11: 968-984
    PubMedGoogle Scholar
  • 2 Pilz S, Kienreich K, Rutters F, de Jongh R, van Ballegooijen AJ, Grubler M, Tomaschitz A, Dekker JM. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Currt Diabetes Rep 2013; 13: 261-270
    PubMedGoogle Scholar
  • 3 Huang C, Shapses SA, Wang X. Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease. Endocr Pract 2013; 19: 712-717
    CrossrefPubMedGoogle Scholar
  • 4 Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr 2010; 92: 1344-1349
    CrossrefPubMedGoogle Scholar
  • 5 Lerchbaum E. Vitamin D and menopause-A narrative review. Maturitas 2014; 79: 3-7
    CrossrefPubMedGoogle Scholar
  • 6 Khosla S, Atkinson EJ, Melton 3rd LJ, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997; 82: 1522-1527
    PubMedGoogle Scholar
  • 7 Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 2006; 38: 317-321
    CrossrefPubMedGoogle Scholar
  • 8 Ellis AC, Alvarez JA, Gower BA, Hunter GR. Cardiorespiratory fitness in older adult women: relationships with serum 25-hydroxyvitamin D. Endocrine 2014; 47: 839-844
    CrossrefPubMedGoogle Scholar
  • 9 Weinert LS. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 2010; 33: e97 author reply e98
    CrossrefPubMedGoogle Scholar
  • 10 Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome?. J Matern Fetal Neonatal Med 2008; 21: 149-157
    CrossrefPubMedGoogle Scholar
  • 11 Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008 198. e521-e525
    PubMedGoogle Scholar
  • 12 Meyers-Seifer CH, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes Care 1996; 19: 1351-1356
    CrossrefPubMedGoogle Scholar
  • 13 O’Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991; 40 (Suppl. 02) 131-135
    CrossrefPubMedGoogle Scholar
  • 14 Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S, Wagner O, Brabant G, Horn R, Stingl H, Schneider B, Waldhausl W, Roden M. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003; 52: 244-251
    CrossrefPubMedGoogle Scholar
  • 15 Ryan AS, McLenithan JC, Zietowski GM. Accelerated metabolic susceptibility to type 2 diabetes in older women with a history of gestational diabetes. Endocr Connect 2013; 2: 79-86
    CrossrefPubMedGoogle Scholar
  • 16 Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int J Obes Rel Metab Disord 1999; 23: 126-132
    CrossrefPubMedGoogle Scholar
  • 17 Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1-9
    PubMedGoogle Scholar
  • 18 Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl. 01) S64-S71
    CrossrefPubMedGoogle Scholar
  • 19 Ryan AS, Ortmeyer HK, Sorkin JD. Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance. Am J Physiol Endocrinol Metab 2012; 302: E145-E152
    CrossrefPubMedGoogle Scholar
  • 20 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
    Google Scholar
  • 21 Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI., KDOQI US. commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014 63. 713-735
    PubMedGoogle Scholar
  • 22 Mallette LE, Beck P, Vandepol C. Malignancy hypercalcemia: evaluation of parathyroid function and response to treatment. Am J Med Sci 1991; 302: 205-210
    CrossrefPubMedGoogle Scholar
  • 23 Holick MF. Vitamin D deficiency. N Eng J Med 2007; 357: 266-281
    CrossrefPubMedGoogle Scholar
  • 24 Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr. SC, Spertus JA, Costa F, American Heart A, National Heart L, Blood I. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
    CrossrefPubMedGoogle Scholar
  • 25 Anonymous. ACSM’s Guidelines for Exercise Testing and Prescription. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013
    Google Scholar
  • 26 Zuhur SS, Erol RS, Kuzu I, Altuntas Y. The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency. Clinics (Sao Paulo) 2013; 68: 658-664
    CrossrefPubMedGoogle Scholar
  • 27 Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R. Vitamin D and Parathyroid Hormone Status in Pregnancy: Impact on Insulin Sensitivity, Beta-cell Function, and Gestational Diabetes Mellitus. J Clin Endocrinol Metab 2014; 99: 4506-4513
    CrossrefPubMedGoogle Scholar
  • 28 Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 2011; 50: 305-312
    CrossrefPubMedGoogle Scholar
  • 29 Mowry DA, Costello MM, Heelan KA. Association among cardiorespiratory fitness, body fat, and bone marker measurements in healthy young females. J Am Osteopat Assoc 2009; 109: 534-539
    PubMedGoogle Scholar
  • 30 To WW, Wong MW. Bone mineral density changes in gestational diabetic pregnancies-a longitudinal study using quantitative ultrasound measurements of the os calcis. Gynecol Endocrinol 2008; 24: 519-525
    CrossrefPubMedGoogle Scholar
  • 31 Schwartz AV. Diabetes Mellitus: Does it Affect Bone?. Calcified Tissue Int 2003; 73: 515-519
    CrossrefPubMedGoogle Scholar
  • 32 Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia 2006; 49: 863-871
    CrossrefPubMedGoogle Scholar
  • 33 Juppner H, Wolf M, Salusky IB. FGF-23: More than a regulator of renal phosphate handling?. J Bone Miner Res 2010; 25: 2091-2097
    CrossrefPubMedGoogle Scholar
  • 34 Kirsztajn GM, Suassuna JH, Bastos MG. Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B. Kidney Int 2009; 76: 462-463 authors’ reply 463–464
    PubMedGoogle Scholar
  • 35 Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health 2005; 95: 1545-1551
    CrossrefPubMedGoogle Scholar
  • 36 Kota S, Jammula S, Kota S, Meher L, Modi K. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density. Indian J Orthop 2013; 47: 402-407
    CrossrefPubMedGoogle Scholar
  • 37 Reid IR, Civitelli R, Halstead LR, Avioli LV, Hruska KA. Parathyroid hormone acutely elevates intracellular calcium in osteoblastlike cells. Am J Physiol 1987; 253: E45-E51
    PubMedGoogle Scholar
  • 38 Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis 1993; 21: 32-38
    CrossrefPubMedGoogle Scholar
  • 39 Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 1991; 129: 3269-3273
    CrossrefPubMedGoogle Scholar
  • 40 Fardella C, Rodriguez-Portales JA. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension. J Endocrinol Invest 1995; 18: 827-832
    CrossrefPubMedGoogle Scholar
  • 41 Jin D, Wu S, Zhang YG, Lu R, Xia Y, Dong H, Sun J. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome. Clin Ther 2015; 37: 996-1009 e7
    CrossrefPubMedGoogle Scholar
  • 42 Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. American journal of physiology Endocrinology and metabolism 2005; 288: E125-E132
    PubMedGoogle Scholar
  • 43 Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930
    CrossrefPubMedGoogle Scholar
  • 44 Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004; 35: 312-319
    CrossrefPubMedGoogle Scholar
  • 45 Cerda D, Peris P, Monegal A, Albaladejo C, Martinez de Osaba MJ, Suris X, Guanabens N. Increase of PTH in post-menopausal osteoporosis. Rev Clin Esp 2011; 211: 338-343
    CrossrefPubMedGoogle Scholar
  • 46 Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM 2005; 98: 667-676
    CrossrefPubMedGoogle Scholar
  • 47 Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2014; 810: 500-525
    PubMedGoogle Scholar
  • 48 Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012; 97: 3557-3568
    CrossrefPubMedGoogle Scholar
  • 49 Wongwiwatthananukit S, Sansanayudh N, Phetkrajaysang N, Krittiyanunt S. Effects of vitamin D(2) supplementation on insulin sensitivity and metabolic parameters in metabolic syndrome patients. J Endocrinol Invest 2013; 36: 558-563
    PubMedGoogle Scholar
  • 50 Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494
    CrossrefPubMedGoogle Scholar
  • 51 Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Pina IL. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Failure 2013; 1: 84-90
    CrossrefPubMedGoogle Scholar
  • 52 Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-323
    CrossrefPubMedGoogle Scholar
  • 53 Kantorovich V, Gacad MA, Seeger LL, Adams JS. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85: 3541-3543
    PubMedGoogle Scholar